Marrone Bio Innovations Inc (MBII) 3.88 $MBII
Marrone Bio Innovations Announces Completion of Audit Committee Investigation; Update on Financial Statement Review and Status of NASDAQ Continued Listing
Business Wire - Wed Feb 04, 3:01PM CST
Marrone Bio Innovations, Inc. (NASDAQ:MBII) today announced the results of the previously announced internal investigation conducted by the Audit Committee of its Board of Directors (the "Committee"
regarding certain accounting and other matters.
MBII: 3.88 (+0.33)
Marrone Bio Innovations' REGALIA(R) MAXX Biofungicide Approved for New Uses in Canada
GlobeNewswire - Thu Jan 22, 9:02AM CST
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that its REGALIA(R) MAXX biofungicide has received approval for new uses in Canada. REGALIA MAXX is a plant extract-based advanced biofungicide that activates plants' natural defenses to boost plant vigor, combat fungal and bacterial diseases, and enhance yield potential.
MBII: 3.88 (+0.33)
Marrone Bio Innovations names James Iademarco as COO
M2 - Thu Jan 15, 3:55AM CST
Plant health company Marrone Bio Innovations (NasdaqGM:MBII) reported on Wednesday the election of James Iademarco as its president and chief operating officer.
MBII: 3.88 (+0.33)
James Iademarco Joins Marrone Bio Innovations as President and Chief Operating Officer
GlobeNewswire - Wed Jan 14, 3:35PM CST
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that James Iademarco has joined the company as its President and Chief Operating Officer. Mr. Iademarco will have responsibility for directing operations of the company, including sales, marketing, manufacturing and corporate infrastructure, with a particular focus on driving sustainable revenue growth.
MBII: 3.88 (+0.33)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 11:47AM CST
ELOS: 10.16 (+0.07), MBII: 3.88 (+0.33), PDFS: 18.31 (+0.04), CASM: 1.36 (-0.01), PHMD: 1.68 (+0.04), EPRS: 7.67 (+0.67), BIND: 6.06 (+0.21), JOB: 0.79 (+0.01), STML: 14.07 (-0.10), BIOD: 1.38 (-0.14), ARO: 3.63 (+0.04), PODD: 32.00 (-0.07), AOI: 1.05 (+0.03), BWEN: 5.48 (+0.15), NBIX: 37.22 (+0.27), VLCCF: 4.15 (-0.06), NEFF: 10.43 (-0.04), PSTR: 4.63 (+0.14), INFI: 15.13 (+0.55), APOL: 25.97 (+0.33)
Monsanto Posts Upbeat Q1 Earnings, Maintains Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 07, 11:21AM CST
Monsanto Company's (MON) first-quarter fiscal 2015 (ended Nov 30, 2014) adjusted earnings came in at 47 cents per share, above the Zacks Consensus Estimate of 34 cents. However, results came 29.9% below the year-ago earnings of 67 cents.
MBII: 3.88 (+0.33), CZZ: 7.85 (-0.10), MON: 124.77 (+2.00), GMK: 45.35 (-0.12)
Study Finds Marrone Bio Innovations' Zequanox(R) Highly Effective for Controlling Zebra Mussel Infestations in Shallow-Water Habitats in Lakes
GlobeNewswire - Tue Jan 06, 7:30AM CST
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products, announced today that the Regional Euro-Asian Biological Invasions Centre (REABIC) has published research from a study of Zequanox(R), a naturally derived biopesticide for controlling zebra mussel infestations in the journal Management of Biological Invasions.
MBII: 3.88 (+0.33)
2014: A Lost Year For Marrone Bio Innovations
Seeking Early Retirement - at Seeking Alpha - Mon Jan 05, 4:05PM CST
MBII: 3.88 (+0.33)
Turnaround potential? 2014's worst performers in the Russell 2000
Seeking Alpha - at Seeking Alpha - Sun Jan 04, 2:49PM CST
KWK: 0.15 (unch), BPZ: 0.25 (unch), EXXI: 4.00 (+0.42), MBII: 3.88 (+0.33), MILL: 2.07 (+0.09), PHMD: 1.68 (+0.04), PRKR: 1.07 (+0.04), RLOC: 3.58 (+0.42), NTLS: 5.19 (+0.05), VTG: 0.52 (-0.02), GDP: 3.58 (+0.29), REN: 1.14 (unch), CYTX: 0.47 (unch), XONE: 16.93 (-0.16), KEG: 2.14 (+0.08), REXX: 5.08 (+0.13), AMZG: 0.65 (-0.03), COVS: 2.47 (+0.11), EXEL: 2.48 (+0.20), ANV: 0.97 (-0.03), VRNG: 0.81 (+0.01), FUEL: 14.30 (+0.65), ZQK: 2.26 (+0.05), GALT: 3.84 (+0.16), EOX: 1.15 (unch), SALT: 2.17 (+0.18), MM: 1.67 (+0.07), WLT: 1.09 (+0.05), NADL: 2.10 (-0.02), QRHC: 1.30 (+0.03), MCP: 0.97 (+0.04), ANR: 1.27 (+0.03), ARO: 3.63 (+0.04), RGDO: 1.17 (+0.02), HERO: 0.92 (+0.02), FWM: 5.55 (+0.08), CONN: 24.69 (-0.07), MPO: 1.00 (-0.02), CVEO: 3.87 (+0.15), SZYM: 2.64 (+0.02)
Can the Rally in Marrone Bio (MBII) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 31, 7:47AM CST
Can the Rally in Marrone Bio (MBII) Shares Continue?
MBII: 3.88 (+0.33)
Marrone Bio Innovations wins REGALIA MAXX Biofungicide's registration in Brazil to control bacterial and fungal diseases across agricultural crops
M2 - Thu Dec 18, 5:14AM CST
Plant health company Marrone Bio Innovations (NasdaqGM:MBI) reported on Wednesday that it has received Brazil's Ministry of Agriculture's (MAPA) registration for REGALIA MAXX Biofungicide to control a wide variety of bacterial and fungal diseases across an array of agricultural crops.
MBI: 8.72 (+0.17), MBII: 3.88 (+0.33)
Marrone Bio Innovations' REGALIA(R) MAXX Biofungicide Receives Registration in Brazil
GlobeNewswire - Wed Dec 17, 8:36AM CST
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that its REGALIA MAXX Biofungicide has received a product registration from Brazil's Ministry of Agriculture (MAPA). Brazil now joins Peru, El Salvador, Guatemala, Honduras, Panama, Columbia, the Dominican Republic and Mexico as Latin American countries having approved the use of REGALIA MAXX to control a wide variety of bacterial and fungal diseases across an array of agricultural crops.
MBII: 3.88 (+0.33)
Global Biologicals Market - Micro Market Monitor 2014
M2 - Fri Dec 12, 4:07AM CST
Research and Markets (http://www.researchandmarkets.com/research/x7snhs/micro_market) has announced the addition of the "Micro Market Monitor: Global Biologicals Market" report to their offering. The global agricultural biologicals market is estimated to grow at a CAGR of 14.6% from 2014 to 2019 Although the mature markets (such as the U.S., Spain, and Italy) hold larger shares in the agricultural biologicals market, the European region is expected to grow at the fastest CAGR of 15.2% during the forecast period, 2014 to 2019. The growth of the agricultural biologicals market is driven by various factors, such as the increasing demand for organic products, rising world population, reduced chemical hazards, and easier residue management. Moreover, emerging economies such as India, China, and Japan are creating huge growth opportunities for the agricultural biologicals market in the Asia-Pacific region. However, factors such as barriers in adoption of biologicals and lack of awareness are restraining the growth of this market. In this report, the global agricultural biologicals market has been broadly classified into three main types, namely biopesticides, biostimulants, and biofertilizers. The biopesticides market segment is estimated to grow at the fastest CAGR from 2014 to 2019, as compared to the other two types. Factors such as phasing out of the prevalence of highly toxic pesticides, improved awareness among farmers regarding the advantages of use of biopesticides, and the increased demand for organic farming are driving the growth of this market. The global agricultural biologicals market is a competitive market with a number of market players with niche technologies. As of 2014, the global agricultural biologicals market is dominated by BASF SE (Germany), Bayer CropScience (Germany), Marrone Bio Innovations, Inc. (U.S.), and Novozymes A/S (Denmark), among others. New product launches, partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to achieve growth in the agricultural biologicals market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Global Agricultural Biologicals Market, By Application 6 Global Agricultural Biologicals Market, By Type 7 Global Agricultural Biologicals Market, By Geography 8 Competitive Landscape 9 Company Profiles - Agrinos As - Basf Se - Bayer Cropscience Ag - Camson Biotechnologies Limited - Certis Usa Llc - Isagro Spa - Koppert B.V. - Marrone Bio Innovation Inc. - Novozymes A/S - T. Stanes & Company Limited - Valent Bio-Science For more information visit http://www.researchandmarkets.com/research/x7...cro_market
MBII: 3.88 (+0.33)
Marrone Bio Innovations to inaugurate new bigger corporate headquarters on 8 December
M2 - Wed Dec 03, 7:05AM CST
Plant health company Marrone Bio Innovations (NasdaqGM:MBII) announced on Tuesday the transfer of its corporate headquarters to 1540 Drew Avenue, Davis, CA 95618, with effect from 8 December 2014.
MBII: 3.88 (+0.33)
Marrone Bio Innovations Announces New Corporate Headquarters Location
GlobeNewswire - Tue Dec 02, 7:39AM CST
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that it has relocated its corporate headquarters to 1540 Drew Avenue, Davis, CA 95618, effective December 8, 2014.
MBII: 3.88 (+0.33)
Marrone Bio Innovations Receives NASDAQ Notice Regarding Late Form 10-Q Filing
Business Wire - Fri Nov 21, 3:01PM CST
Marrone Bio Innovations, Inc. (MBI) (NASDAQ:MBII) today announced that, as anticipated, it has received a letter from the Listing Qualifications Department of The NASDAQ Stock Market LLC ("NASDAQ" notifying MBI of its noncompliance with NASDAQ Listing Rule 5250(c)(1) as a result of the company's filing of a Notification of Late Filing on Form 12b-25 on November 14, 2014. In the Form 12b-25, the company indicated that the filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2014 (the "Form 10-Q" will be delayed until after the completion of the previously-disclosed internal investigation by the Company's Audit Committee regarding certain accounting matters.
MBII: 3.88 (+0.33)
Marrone Bio Innovations' Marrone Michigan Manufacturing Facility Recognized by the Michigan Agri-Business Association for Contributions to Sustainable Agriculture
GlobeNewswire - Thu Nov 13, 7:30AM CST
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, is pleased to announce that its Marrone Michigan Manufacturing (M3) facility in Bangor, Michigan has received a 2014 "Green Agribusiness Award" from the Michigan Agri-Business Association (MABA).
MBII: 3.88 (+0.33)
Schubert Law Firm Launches Investigation into Marrone Bio Innovations' Top Executives Regarding Possible Breaches of Their Fiduciary Duties
PR Newswire - Wed Nov 12, 10:00AM CST
Shareholder and consumer rights law firm Schubert Jonckheer & Kolbe LLP today launched an investigation into whether certain officers and directors of Marrone Bio Innovations, Inc. (NASDAQ: MBII) breached their fiduciary duties to Marrone Bio and its shareholders.
MBII: 3.88 (+0.33)
Air Products to Launch Gas Blending System at FABTECH - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 5:35PM CST
Air Products (APD) will launch its Maxx Pak portable shielding gas blending system at FABTECH 2014.
MBII: 3.88 (+0.33), CE: 57.98 (+0.22), HUN: 24.40 (+0.22), APD: 152.81 (+0.59)
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Marrone Bio Innovations, Inc. and Certain Officers - MBII
PR Newswire - Fri Oct 31, 2:13PM CDT
Pomerantz LLP has filed a class action lawsuit against Marrone Bio Innovations, Inc. ("Marrone" or the "Company" (NASDAQ: MBII) and certain of its officers. The class action, filed in United States District Court, Eastern District of California, and docketed under 14-cv-02055, is on behalf of a class consisting of all persons or entities who purchased Marrone securities between March 6, 2014 and September 2, 2014, inclusive (the "Class Period" . This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act" .
MBII: 3.88 (+0.33)
Marrone Bio Innovations Announces Completion of Audit Committee Investigation; Update on Financial Statement Review and Status of NASDAQ Continued Listing
Business Wire - Wed Feb 04, 3:01PM CST
Marrone Bio Innovations, Inc. (NASDAQ:MBII) today announced the results of the previously announced internal investigation conducted by the Audit Committee of its Board of Directors (the "Committee"
regarding certain accounting and other matters. MBII: 3.88 (+0.33)
Marrone Bio Innovations' REGALIA(R) MAXX Biofungicide Approved for New Uses in Canada
GlobeNewswire - Thu Jan 22, 9:02AM CST
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that its REGALIA(R) MAXX biofungicide has received approval for new uses in Canada. REGALIA MAXX is a plant extract-based advanced biofungicide that activates plants' natural defenses to boost plant vigor, combat fungal and bacterial diseases, and enhance yield potential.
MBII: 3.88 (+0.33)
Marrone Bio Innovations names James Iademarco as COO
M2 - Thu Jan 15, 3:55AM CST
Plant health company Marrone Bio Innovations (NasdaqGM:MBII) reported on Wednesday the election of James Iademarco as its president and chief operating officer.
MBII: 3.88 (+0.33)
James Iademarco Joins Marrone Bio Innovations as President and Chief Operating Officer
GlobeNewswire - Wed Jan 14, 3:35PM CST
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that James Iademarco has joined the company as its President and Chief Operating Officer. Mr. Iademarco will have responsibility for directing operations of the company, including sales, marketing, manufacturing and corporate infrastructure, with a particular focus on driving sustainable revenue growth.
MBII: 3.88 (+0.33)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 11:47AM CST
ELOS: 10.16 (+0.07), MBII: 3.88 (+0.33), PDFS: 18.31 (+0.04), CASM: 1.36 (-0.01), PHMD: 1.68 (+0.04), EPRS: 7.67 (+0.67), BIND: 6.06 (+0.21), JOB: 0.79 (+0.01), STML: 14.07 (-0.10), BIOD: 1.38 (-0.14), ARO: 3.63 (+0.04), PODD: 32.00 (-0.07), AOI: 1.05 (+0.03), BWEN: 5.48 (+0.15), NBIX: 37.22 (+0.27), VLCCF: 4.15 (-0.06), NEFF: 10.43 (-0.04), PSTR: 4.63 (+0.14), INFI: 15.13 (+0.55), APOL: 25.97 (+0.33)
Monsanto Posts Upbeat Q1 Earnings, Maintains Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 07, 11:21AM CST
Monsanto Company's (MON) first-quarter fiscal 2015 (ended Nov 30, 2014) adjusted earnings came in at 47 cents per share, above the Zacks Consensus Estimate of 34 cents. However, results came 29.9% below the year-ago earnings of 67 cents.
MBII: 3.88 (+0.33), CZZ: 7.85 (-0.10), MON: 124.77 (+2.00), GMK: 45.35 (-0.12)
Study Finds Marrone Bio Innovations' Zequanox(R) Highly Effective for Controlling Zebra Mussel Infestations in Shallow-Water Habitats in Lakes
GlobeNewswire - Tue Jan 06, 7:30AM CST
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products, announced today that the Regional Euro-Asian Biological Invasions Centre (REABIC) has published research from a study of Zequanox(R), a naturally derived biopesticide for controlling zebra mussel infestations in the journal Management of Biological Invasions.
MBII: 3.88 (+0.33)
2014: A Lost Year For Marrone Bio Innovations
Seeking Early Retirement - at Seeking Alpha - Mon Jan 05, 4:05PM CST
MBII: 3.88 (+0.33)
Turnaround potential? 2014's worst performers in the Russell 2000
Seeking Alpha - at Seeking Alpha - Sun Jan 04, 2:49PM CST
KWK: 0.15 (unch), BPZ: 0.25 (unch), EXXI: 4.00 (+0.42), MBII: 3.88 (+0.33), MILL: 2.07 (+0.09), PHMD: 1.68 (+0.04), PRKR: 1.07 (+0.04), RLOC: 3.58 (+0.42), NTLS: 5.19 (+0.05), VTG: 0.52 (-0.02), GDP: 3.58 (+0.29), REN: 1.14 (unch), CYTX: 0.47 (unch), XONE: 16.93 (-0.16), KEG: 2.14 (+0.08), REXX: 5.08 (+0.13), AMZG: 0.65 (-0.03), COVS: 2.47 (+0.11), EXEL: 2.48 (+0.20), ANV: 0.97 (-0.03), VRNG: 0.81 (+0.01), FUEL: 14.30 (+0.65), ZQK: 2.26 (+0.05), GALT: 3.84 (+0.16), EOX: 1.15 (unch), SALT: 2.17 (+0.18), MM: 1.67 (+0.07), WLT: 1.09 (+0.05), NADL: 2.10 (-0.02), QRHC: 1.30 (+0.03), MCP: 0.97 (+0.04), ANR: 1.27 (+0.03), ARO: 3.63 (+0.04), RGDO: 1.17 (+0.02), HERO: 0.92 (+0.02), FWM: 5.55 (+0.08), CONN: 24.69 (-0.07), MPO: 1.00 (-0.02), CVEO: 3.87 (+0.15), SZYM: 2.64 (+0.02)
Can the Rally in Marrone Bio (MBII) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 31, 7:47AM CST
Can the Rally in Marrone Bio (MBII) Shares Continue?
MBII: 3.88 (+0.33)
Marrone Bio Innovations wins REGALIA MAXX Biofungicide's registration in Brazil to control bacterial and fungal diseases across agricultural crops
M2 - Thu Dec 18, 5:14AM CST
Plant health company Marrone Bio Innovations (NasdaqGM:MBI) reported on Wednesday that it has received Brazil's Ministry of Agriculture's (MAPA) registration for REGALIA MAXX Biofungicide to control a wide variety of bacterial and fungal diseases across an array of agricultural crops.
MBI: 8.72 (+0.17), MBII: 3.88 (+0.33)
Marrone Bio Innovations' REGALIA(R) MAXX Biofungicide Receives Registration in Brazil
GlobeNewswire - Wed Dec 17, 8:36AM CST
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that its REGALIA MAXX Biofungicide has received a product registration from Brazil's Ministry of Agriculture (MAPA). Brazil now joins Peru, El Salvador, Guatemala, Honduras, Panama, Columbia, the Dominican Republic and Mexico as Latin American countries having approved the use of REGALIA MAXX to control a wide variety of bacterial and fungal diseases across an array of agricultural crops.
MBII: 3.88 (+0.33)
Global Biologicals Market - Micro Market Monitor 2014
M2 - Fri Dec 12, 4:07AM CST
Research and Markets (http://www.researchandmarkets.com/research/x7snhs/micro_market) has announced the addition of the "Micro Market Monitor: Global Biologicals Market" report to their offering. The global agricultural biologicals market is estimated to grow at a CAGR of 14.6% from 2014 to 2019 Although the mature markets (such as the U.S., Spain, and Italy) hold larger shares in the agricultural biologicals market, the European region is expected to grow at the fastest CAGR of 15.2% during the forecast period, 2014 to 2019. The growth of the agricultural biologicals market is driven by various factors, such as the increasing demand for organic products, rising world population, reduced chemical hazards, and easier residue management. Moreover, emerging economies such as India, China, and Japan are creating huge growth opportunities for the agricultural biologicals market in the Asia-Pacific region. However, factors such as barriers in adoption of biologicals and lack of awareness are restraining the growth of this market. In this report, the global agricultural biologicals market has been broadly classified into three main types, namely biopesticides, biostimulants, and biofertilizers. The biopesticides market segment is estimated to grow at the fastest CAGR from 2014 to 2019, as compared to the other two types. Factors such as phasing out of the prevalence of highly toxic pesticides, improved awareness among farmers regarding the advantages of use of biopesticides, and the increased demand for organic farming are driving the growth of this market. The global agricultural biologicals market is a competitive market with a number of market players with niche technologies. As of 2014, the global agricultural biologicals market is dominated by BASF SE (Germany), Bayer CropScience (Germany), Marrone Bio Innovations, Inc. (U.S.), and Novozymes A/S (Denmark), among others. New product launches, partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to achieve growth in the agricultural biologicals market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Global Agricultural Biologicals Market, By Application 6 Global Agricultural Biologicals Market, By Type 7 Global Agricultural Biologicals Market, By Geography 8 Competitive Landscape 9 Company Profiles - Agrinos As - Basf Se - Bayer Cropscience Ag - Camson Biotechnologies Limited - Certis Usa Llc - Isagro Spa - Koppert B.V. - Marrone Bio Innovation Inc. - Novozymes A/S - T. Stanes & Company Limited - Valent Bio-Science For more information visit http://www.researchandmarkets.com/research/x7...cro_market
MBII: 3.88 (+0.33)
Marrone Bio Innovations to inaugurate new bigger corporate headquarters on 8 December
M2 - Wed Dec 03, 7:05AM CST
Plant health company Marrone Bio Innovations (NasdaqGM:MBII) announced on Tuesday the transfer of its corporate headquarters to 1540 Drew Avenue, Davis, CA 95618, with effect from 8 December 2014.
MBII: 3.88 (+0.33)
Marrone Bio Innovations Announces New Corporate Headquarters Location
GlobeNewswire - Tue Dec 02, 7:39AM CST
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that it has relocated its corporate headquarters to 1540 Drew Avenue, Davis, CA 95618, effective December 8, 2014.
MBII: 3.88 (+0.33)
Marrone Bio Innovations Receives NASDAQ Notice Regarding Late Form 10-Q Filing
Business Wire - Fri Nov 21, 3:01PM CST
Marrone Bio Innovations, Inc. (MBI) (NASDAQ:MBII) today announced that, as anticipated, it has received a letter from the Listing Qualifications Department of The NASDAQ Stock Market LLC ("NASDAQ"
notifying MBI of its noncompliance with NASDAQ Listing Rule 5250(c)(1) as a result of the company's filing of a Notification of Late Filing on Form 12b-25 on November 14, 2014. In the Form 12b-25, the company indicated that the filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2014 (the "Form 10-Q" will be delayed until after the completion of the previously-disclosed internal investigation by the Company's Audit Committee regarding certain accounting matters. MBII: 3.88 (+0.33)
Marrone Bio Innovations' Marrone Michigan Manufacturing Facility Recognized by the Michigan Agri-Business Association for Contributions to Sustainable Agriculture
GlobeNewswire - Thu Nov 13, 7:30AM CST
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, is pleased to announce that its Marrone Michigan Manufacturing (M3) facility in Bangor, Michigan has received a 2014 "Green Agribusiness Award" from the Michigan Agri-Business Association (MABA).
MBII: 3.88 (+0.33)
Schubert Law Firm Launches Investigation into Marrone Bio Innovations' Top Executives Regarding Possible Breaches of Their Fiduciary Duties
PR Newswire - Wed Nov 12, 10:00AM CST
Shareholder and consumer rights law firm Schubert Jonckheer & Kolbe LLP today launched an investigation into whether certain officers and directors of Marrone Bio Innovations, Inc. (NASDAQ: MBII) breached their fiduciary duties to Marrone Bio and its shareholders.
MBII: 3.88 (+0.33)
Air Products to Launch Gas Blending System at FABTECH - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 5:35PM CST
Air Products (APD) will launch its Maxx Pak portable shielding gas blending system at FABTECH 2014.
MBII: 3.88 (+0.33), CE: 57.98 (+0.22), HUN: 24.40 (+0.22), APD: 152.81 (+0.59)
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Marrone Bio Innovations, Inc. and Certain Officers - MBII
PR Newswire - Fri Oct 31, 2:13PM CDT
Pomerantz LLP has filed a class action lawsuit against Marrone Bio Innovations, Inc. ("Marrone" or the "Company"
(NASDAQ: MBII) and certain of its officers. The class action, filed in United States District Court, Eastern District of California, and docketed under 14-cv-02055, is on behalf of a class consisting of all persons or entities who purchased Marrone securities between March 6, 2014 and September 2, 2014, inclusive (the "Class Period" . This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act" . MBII: 3.88 (+0.33)
